Table 3:
Animal Model | Reference | Stages in Ovarian Follicular Development | Remarks | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Species | Treatment | Reserve Establishment |
Reserve Depletion |
Activation /Recruitment |
Selection | Dominance | Ovulation | Luteal Phase |
||
Rhesus Macaques |
Testosterone GD 40- 55/65/75 (term 164) |
Abbott et al 2005 |
B* | B* | B* | Anovulation; polyfollicular ovarian morphology |
||||
Rhesus Macaques |
Testosterone GD 100/115- 124/139 (term 164) |
Abbott et al 2005 |
B* | B* | B* | Anovulation; polyfollicular ovarian morphology |
||||
Baboon | Letrozole GD 100–164 (term 184) |
Zachos et al., 2002 |
↓ | ↓ | Ovarian outer cortex has fewer follicles and more interfollicular nests in fetuses. Adult ovarian phenotype not assessed |
|||||
Sufflock Sheep |
Testosterone GD 30–90 (term 147) |
Padmanabhan & Veiga-Lopez 2013b |
↑ | ↑ | B | B | B | B | Multifollicular phenotype; reduced primordial and increase in other follicular classes; anovulation |
|
Sufflock Sheep |
Testosterone GD 60–90 (term 147) |
Steckler et al., 2007 Veiga-Lopez et al, 2016 |
↓* | Altered intrafollicular steroids; Reduced fecundity |
||||||
Sufflock Sheep |
DHT GD 30–90 (term 147) |
Padmanabhan & Veiga-Lopez 2013b |
↑ | ↑ | Decrease in percentage of primordial follicles with corresponding increase in other follicular classes in fetal ovary |
|||||
Scottish Greyface x Texel Sheep |
Testosterone GD 62–102 (term 147) |
Hogg et al., 2011 Hogg et al., 2012 |
No changes in ovarian morphology or follicular counts at fetal and 11 months of age |
|||||||
Rat (Sprague Dawley) |
Testosterone GD 16–19 (term 21) |
Wu et al., 2010 | ↑* | B* | B* | Increase in preantral and antral follicles; fewer preovulatory follicles and corpus luteum |
||||
Rat (Sprague Dawley) |
DHT GD 16–19 (term 21) |
Wu et al., 2010 | ↑* | B* | B* | Increase in preantral and antral follicles; fewer preovulatory follicles and corpus luteum |
||||
Mouse | DHT GD 16–18 (term 20) |
Rolland et al., 2010 |
B* | Longer estrous cycle | ||||||
Rat# (Wistar) |
DHT 21–111d PN |
Manneras et al., 2007 |
B* | B* | B* | Multiple Cystic follicles | ||||
Rat# (Wistar) |
Letrozole 21–111d PN |
Manneras et al., 2007 |
B* | B* | B* | Multiple Cystic follicles | ||||
Rat# (Wistar) |
Letrozole 34–55d PN |
Kafali et al 2004 |
B* | B* | B* | Multiple Cystic follicles | ||||
Rat# (Wistar) |
Letrozole 56–77d PN |
Baravalle et al 2006 |
B* | B* | B* | Multiple Cystic follicles | ||||
Mouse# | Letrozole 28–63d PN |
Kauffman et al., 2015 |
B* | B* | B* | Multiple Cystic follicles | ||||
Rat# (Wistar) |
Estradiol Valerate 14d PN |
Rosa-E-Silva et al., 2003 | B* | B* | B* | Multiple Cystic follicles | ||||
Mouse | Estradiol 1–4d PN |
Karowan and Pepling 2012 Chen et al 2007 |
↓ | ↓ | ↓ | Impaired germ cell nest breakdown; increased primordial follicle numbers |
||||
Mouse (CD1) |
Ethinyl estradiol 1–4d PN |
Karowan and Pepling 2012 |
↓ | ↓ | ↓ | Impaired germ cell nest breakdown and increased primordial follicle numbers |
GD = Gestational day; DHT = Dihydrotestosterone; PN = postnatal. ↑ Increase; ↓ Decrease; B Blocked;
Indicates the affected follicular developmental stage is predicted based on the phenotype observed;
Indicates animal models with treatments outside the ovarian developmental window.